An oncologist explains the situations when doctors recommend getting screened for colorectal cancer before age 45.
Early-phase clinical trials involving PIM-1 kinase inhibitors look promising. In the evolving landscape of myelofibrosis (MF) ...
8NewsNow.com on MSN
Colon Cancer Awareness with Intermountain Health
March is Colon Cancer Awareness month. According to a study published in January 2026 by the Journal of American Medical Association, colorectal cancer is now the leading cause of cancer-related death ...
Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...
Colorectal cancer is increasing in younger patients and is now the leading cause of cancer death in those under age 50, yet those patients lack support.
The Hearty Soul on MSN
Doctors can spot diabetes and cancer in your eyes. Are you missing the signs?
The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...
Everyday Health on MSN
7 healthy foods women should eat during menopause
During menopause, your nutritional needs may change. Here, get recommendations for foods that are rich in key nutrients to help ease menopause symptoms.
When this happens, it can lead to autoimmune diseases such as rheumatoid arthritis, lupus, or aplastic anemia. Scientists have long wondered why this happens and why some people with blood cancers ...
“[I thought] I had an intolerance to vodka," said Claire Dougherty ...
News-Medical.Net on MSN
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
In 2025, we were very pleased to report tremendous progress across all pillars of the company. First of all, in business development, we were delighted with the progress in our collaboration with MSD ...
Strong capital position of $667.2 million in cash, cash equivalents and short-term investments, together with $180 million in anticipated collaboration payments, expected to support advancement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results